p.118 抽出テキスト

tion: Multimodality Imaging for Therapeutic Strategies and Interventions. JACC Cardiovasc Imaging 2016; 9: 1318-1337. PMID: 27832900 312. Spain MG, Smith MD, Kwan OL, et al. Effect of isometric exercise on mitral and aortic regurgitation as assessed by color Doppler flow imaging. Am J Cardiol 1990; 65: 78-83. PMID: 2294685 313. Curio J, Tarar W, Al-Hindwan HSA, et al. The MitraClip Procedure in Patients With Moderate Resting but Severe Exercise-Induced Mitral Regurgitation. J Invasive Cardiol 2020; 32: E1-E8. PMID: 31893503 314. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999; 99: 400-405. PMID: 9918527 315. Gillinov AM, Mihaljevic T, Blackstone EH, et al. Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop? Ann Thorac Surg 2010; 90: 481-488. PMID: 20667334 316. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 1994; 24: 1536-1543. PMID: 7930287 317. Kitai T, Okada Y, Shomura Y, et al. Early surgery for asymptomatic mitral regurgitation: importance of atrial fibrillation. J Heart Valve Dis 2012; 21: 61-70. PMID: 22474744 318. Enriquez-Sarano M, Suri RM, Clavel MA, et al. Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation. J Thorac Cardiovasc Surg 2015; 150: 50-58. PMID: 25986494 319. Ghoreishi M, Evans CF, DeFilippi CR, et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 2011; 142: 1439-1452. PMID: 21962906 320. Coutinho GF, Garcia AL, Correia PM, et al. Negative impact of atrial fibrillation and pulmonary hypertension after mitral valve surgery in asymptomatic patients with severe mitral regurgitation: a 20-year follow-up. Eur J Cardiothorac Surg 2015; 48: 548-556. PMID: 25564214 321. Ngaage DL, Schaff HV, Mullany CJ, et al. Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified? Ann Thorac Surg 2007; 84: 434-443. PMID: 17643612 322. Le Tourneau T, Messika-Zeitoun D, Russo A, et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 2010; 56: 570-578. PMID: 20688212 323. David TE, Ivanov J, Armstrong S, et al. Late outcomes of mitral valve repair for floppy valves: Implications for asymptomatic patients. J Thorac Cardiovasc Surg 2003; 125: 1143-1152. PMID: 12771888 324. Suri RM, Vanoverschelde JL, Grigioni F, et al. Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA 2013; 310: 609-616. PMID: 23942679 325. Kang DH, Park SJ, Sun BJ, et al. Early surgery versus conventional treatment for asymptomatic severe mitral regurgitation: a propensity analysis. J Am Coll Cardiol 2014; 63: 2398-2407. PMID: 24694528 326. Otsuji Y, Handschumacher MD, Liel-Cohen N, et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol 2001; 37: 641-648. PMID: 11216991 327. Watanabe N, Ogasawara Y, Yamaura Y, et al. Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography. J Am Coll Cardiol 2005; 45: 763-769. PMID: 15734623 328. Lee LS, Kwon MH, Cevasco M, et al. Postoperative recurrence of mitral regurgitation after annuloplasty for functional mitral regurgitation. Ann Thorac Surg 2012; 94: 1211-1217. PMID: 22727322 329. Takahashi Y, Abe Y, Sasaki Y, et al. Mitral valve repair for atrial functional mitral regurgitation in patients with chronic atrial fibrillation. Interact Cardiovasc Thorac Surg 2015; 21: 163-168. PMID: 25980774 330. Machino-Ohtsuka T, Seo Y, Ishizu T, et al. Novel Mechanistic Insights Into Atrial Functional Mitral Regurgitation - 3-Dimensional Echocardiographic Study. Circ J 2016; 80: 2240-2248. PMID: 27535338 331. Blais C, Dumesnil JG, Baillot R, et al. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 2003; 108: 983-988. PMID: 12912812 332. Tasca G, Mhagna Z, Perotti S, et al. Impact of prosthesis-patient mismatch on cardiac events and midterm mortality after aortic valve re- placement in patients with pure aortic stenosis. Circulation 2006; 113: 570-576. PMID: 16401767 333. Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol 2010; 55: 2413-2426. PMID: 20510209 334. Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 2013; 61: 1585-1595. PMID: 23500308 335. Chakravarty T, Abramowitz Y, Jilaihawi H, et al. Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing? EuroIntervention 2016; 12 Suppl: Y28-Y32. PMID: 27640027 336. Mylotte D, Andalib A, Thériault-Lauzier P, et al. Transcatheter heart valve failure: a systematic review. Eur Heart J 2015; 36: 1306-1327. PMID: 25265974 337. De Backer O, Dangas GD, Jilaihawi H, et al. GALILEO-4D Investigators. Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. N Engl J Med 2020; 382: 130-139. PMID: 31733182 338. 日本循環器学会.循環器病の診断と治療に関するガイドライン(2008年度合同研究班報告):急性および慢性心筋炎の診断・治療

に関するガイドライン(2009年改訂版).https://www.j-circ.or.jp/ cms/wp-content/uploads/2020/02/JCS2009_izumi_h.pdf 339. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006; 113: 876-890. PMID: 16476862 340. Kato S, Morimoto S, Hiramitsu S, et al. Risk factors for patients developing a fulminant course with acute myocarditis. Circ J 2004; 68: 734-739. PMID: 15277731 341. Ammirati E, Cipriani M, Lilliu M, et al. Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis. Circulation 2017; 136: 529-545. PMID: 28576783 342. Pinamonti B, Alberti E, Cigalotto A, et al. Echocardiographic findings in myocarditis. Am J Cardiol 1988; 62: 285-291. PMID: 3400607 343. James KB, Lee K, Thomas JD, et al. Left ventricular diastolic dysfunction in lymphocytic myocarditis as assessed by Doppler echocardiography. Am J Cardiol 1994; 73: 282-285. PMID: 8296760 344. Felker GM, Boehmer JP, Hruban RH, et al. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 2000; 36: 227-232. PMID: 10898439 345. Nieminen MS, Heikkilä J, Karjalainen J. Echocardiography in acute infectious myocarditis: relation to clinical and electrocardiographic findings. Am J Cardiol 1984; 53: 1331-1337. PMID: 6711435 346. Hiramitsu S, Morimoto S, Kato S, et al. Significance of transient left ventricular wall thickening in acute lymphocytic myocarditis. Heart Vessels 2007; 22: 25-29. PMID: 17285442 347. Kociol RD, Cooper LT, Fang JC, et al. American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association. Circulation 2020; 141: e69-e92. PMID: 31902242 348. Stainback RF, Estep JD, Agler DA, et al. American Society of Echocardiography. Echocardiography in the Management of Patients with Left Ventricular Assist Devices: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 2015; 28: 853-909. PMID: 26239899 349. 日本循環器学会,日本心不全学会.心筋症診療ガイドライン(2018年改訂版).https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2018_tsutsui_kitaoka.pdf 350. Fighali S, Krajcer Z, Edelman S, et al. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 1987; 9: 288-294. PMID: 3805517 351. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: e212-e260. PMID: 22075469 352. Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-2779. PMID: 25173338 353. Kitaoka H, Doi Y, Casey SA, et al. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 2003; 92: 1183-1186. PMID: 14609593 354. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomy-